(Q34616010)

3 August 2017

1 reference

title

Treatment of liver metastases, an update on the possibilities and results (English)

1 reference

3 August 2017

Ruers T

1

1 reference

3 August 2017

Bleichrodt RP

series ordinal

2

1 reference

3 August 2017

publication date

1 May 2002

1 reference

European Journal of Cancer

3 August 2017

published in

1 reference

3 August 2017

volume

38

1 reference

3 August 2017

issue

7

1 reference

3 August 2017

page(s)

1023-1033

1 reference

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Factors influencing the natural history of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Resection of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Liver resection for colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Hepatic resection for metastatic colorectal cancer results in cure for some patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Resection of liver metastases from colorectal cancer: the real impact of the surgical margin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Resection of hepatic and pulmonary metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Hepatic lymph node involvement in resected cases of liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Results of extensive surgery for liver metastases in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

1 reference

7 January 2021

Accuracy of intraoperative ultrasonography in diagnosing liver metastasis from colorectal cancer: evaluation with postoperative follow-up results

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Role of staging laparoscopy in the treatment of hepatic malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

False-positive CT portography: correlation with pathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Evaluation of benign vs malignant hepatic lesions with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Hepatic resections for colorectal metastases in The Netherlands. A multiinstitutional 10-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Resection of liver metastases of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

A study of prognostic factors for hepatic resection for colorectal metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Cryotherapy of the resection edge after liver resection for colorectal cancer metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Place of cryosurgery in the treatment of malignant liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Repeated liver resection for recurrent liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Repeat hepatectomy for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

A new technique for hepatic infusional chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

A 5-Year Study of Cryosurgery in the Treatment of Liver Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Treatment of colorectal liver metastases by cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Long-term results of treating hepatic colorectal metastases with cryosurgery

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Cryoablation of unresectable malignant liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Cryosurgical ablation of hepatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Radiofrequency Ablation of 100 Hepatic Metastases with a Mean Follow-Up of More Than 1 Year

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Radiofrequency thermal ablation of hepatic metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Radiofrequency ablation of unresectable hepatic malignancies: lessons learned

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Thermal ablation of liver metastases. Current status and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Preoperative portal vein embolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Portal vein embolization: rationale, technique and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900059-X

7 January 2021

10.1016/S0959-8049(02)00059-X

Identifiers

DOI

1 reference

3 August 2017

1 reference